Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV‐1 Entry via the CCR5 Co‐Receptor
Open Access
- 1 September 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (5) , 739-744
- https://doi.org/10.1086/655661
Abstract
An effective vaginal microbicide could reduce human immunodeficiency virus type 1 (HIV-1) transmission to women. Among microbicide candidates in clinKeywords
This publication has 27 references indexed in Scilit:
- Targeting early infection to prevent HIV-1 mucosal transmissionNature, 2010
- Selection of a Simian-Human Immunodeficiency Virus Strain Resistant to a Vaginal Microbicide in MacaquesJournal of Virology, 2009
- Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1The Journal of Experimental Medicine, 2009
- Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal RingAIDS Research and Human Retroviruses, 2009
- Vaginal Drug Delivery Systems for HIV PreventionThe AAPS Journal, 2009
- Whither or Wither Microbicides?Science, 2008
- Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infectionRetrovirology, 2008
- Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitorNature Medicine, 2005
- Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency virusesVirology, 2004
- Progesterone implants enhance SIV vaginal transmission and early virus loadNature Medicine, 1996